Display Settings:

Format

Send to:

Choose Destination

    Genome Biol. 2006;7(8):230.

    Unraveling the transcriptional network controlling ES cell pluripotency.

    Rao S, Orkin SH.

    Division of Hematology-Oncology, Children's Hospital and the Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

    Embryonic stem cells (ES cells) are powerful tools for genetic engineering and hold significant potential for regenerative medicine. Recent work provides new insights into ES cell pluripotency and delineates separate transcriptional pathways in ES cells for maintenance of the undifferentiated state and for self-renewal.

    PMID: 16942632 [PubMed - indexed for MEDLINE]

    PMCID: 1779601

    Supplemental Content

    Click here to read Click here to read